methylprednisolone has been researched along with Central Serous Chorioretinopathy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ku, M; Rao, Q; Wan, Q | 1 |
| Gao, X; Li, X | 1 |
| Ito, S; Kuroda, T; Murakami, S; Murasawa, A; Nagai, S; Nakano, M; Narita, I; Sato, H; Wada, Y | 1 |
1 review(s) available for methylprednisolone and Central Serous Chorioretinopathy
| Article | Year |
|---|---|
A case report of systemic lupus erythematosus combined with central serous chorioretinopathy treated with glucocorticoids.
Topics: Adult; Central Serous Chorioretinopathy; Eye; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Young Adult | 2023 |
2 other study(ies) available for methylprednisolone and Central Serous Chorioretinopathy
| Article | Year |
|---|---|
Development of bullous retinal detachment during systemic corticosteroid treatment.
Topics: Administration, Oral; Central Serous Chorioretinopathy; Diagnostic Errors; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections, Intravenous; Methylprednisolone; Middle Aged; Prednisolone; Retinal Detachment; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome | 2011 |
Atypical severe central serous chorioretinopathy in a patient with systemic lupus erythematosus improved with a rapid reduction in glucocorticoid.
Topics: Adult; Central Serous Chorioretinopathy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methylprednisolone; Prednisolone; Recovery of Function; Tacrolimus; Treatment Outcome; Vision Disorders; Visual Acuity | 2013 |